Author: OurCrowd

[DreaMed in DreaMed] DreaMed receives 5th FDA Clearance

TEL AVIV, Israel: DreaMed Diabetes LTD. (“DreaMed” or the “Company”), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes patients who use insulin pumps or injections and monitor their glucose using continuous glucose monitor and/or blood glucose meters. Read...

Read More

[NanoLock in VM Blog] NanoLock Security 2024 predictions: Cyberattack growth against critical infrastructure & factories

As worldwide financial instability continues, most regions will see a massive surge in cyberattacks in the industrial sector. While ransomware is more commonly reported as the main avenue of cyber attacks, OT (operational technology) attacks are significantly more impactful. Most organizations have more focus on IT and less of a focus on OT , however, OT attacks can have the most impact – completely shutting down production. Read...

Read More

[Hub Security in News Direct] HUB Cyber Security Ltd. participates in strengthening Israel’s digital defenses amidst escalating cyber threats

Tel-Aviv, Israel – October 19, 2023 — In response to a significant increase in cyber-attacks on Israeli online government authorities and enterprises, including a recentcyberattack on Israel’s Airforce website, HUB Cyber Security Ltd. (Nasdaq: UBC), a developer of Confidential Computing cybersecurity solutions and services (“HUB Security&; or the “Company”), announces its participation in the nation’s digital ‘Fortress’defenses. HUB Security will provide superior defenses to national infrastructures in thewake of the urgent need for robust cybersecurity measures. Read more...

Read More

[Surgical Theater in PR Newswire] Surgical Theater announces first augmented reality spine surgery at Stanford Medicine successfully executed with SyncAR® Spine

SAN FRANCISCO, Oct. 19, 2023 /PRNewswire/ — Surgical Theater is proud to announce a groundbreaking achievement with Stanford Medicine performing the first spine surgery utilizing its augmented reality technology. The augmented reality spine surgery was done using Surgical Theater SyncAR® Spine, which integrates the Microsoft HoloLens headsets. Stanford Medicine and Surgical Theater, longstanding partners in the quest for innovation in XR (Extended Reality) surgical care, are once again at the forefront of medical advancement with this cutting-edge technology being used in the operating room. Read...

Read More